UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000023610 |
|---|---|
| Receipt number | R000027184 |
| Scientific Title | Evaluation of the usefulness of personalized 3D image software and printed model in partial nephrectomy |
| Date of disclosure of the study information | 2016/09/01 |
| Last modified on | 2018/08/18 16:46:05 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation of the usefulness of personalized 3D image software and printed model in partial nephrectomy
Acronym
Evaluation of the usefulness of personalized 3D image software and printed model in partial nephrectomy
Scientific Title
Evaluation of the usefulness of personalized 3D image software and printed model in partial nephrectomy
Scientific Title:Acronym
Evaluation of the usefulness of personalized 3D image software and printed model in partial nephrectomy
Region
| Japan |
Condition
Condition
renal tumor
Classification by specialty
| Urology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the usefulness of 3D imaging soft,CMMed, and personalized 3D printed model as simulation in partial nephrectomy
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
3D imaging soft
validity of expected feeding artery
3D printed model
tumor excised plane
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Diagnosis
Type of intervention
| Medicine |
Interventions/Control_1
intravenous administration of ICG ( indocyanine green)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) PS 0 or 1
2) 20 years old over at the acquisition of the consent
3) no severe abnormality of cardioplumonary, liver and renal function
4) contrast CT is performed
5) no contraindication of administration of ICG
6) the written consent of the patient has been obtained for this clinical trial
Key exclusion criteria
When there is request of the cancellation
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Tetsuya Yoshida |
Organization
Shiga university of medical science
Division name
department of urology
Zip code
Address
Seta Tsukinowa-cho, Otsu City,Shiga,JAPAN
TEL
077-548-2273
hquro@belle.shiga-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Tetsuya Yoshida |
Organization
Shiga university of medical science
Division name
department of urology
Zip code
Address
Seta Tsukinowa-cho, Otsu City,Shiga,JAPAN
TEL
077-548-2273
Homepage URL
hquro@belle.shiga-med.ac.jp
Sponsor or person
Institute
Shiga university of medical science
Institute
Department
Personal name
Funding Source
Organization
Shiga university of medical science
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 09 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2016 | Year | 08 | Month | 05 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 09 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2016 | Year | 08 | Month | 12 | Day |
Last modified on
| 2018 | Year | 08 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027184
